BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 13, 2025
See today's BioWorld
Home
» Regulatory actions for Aug. 18, 2021
To read the full article
sign up for free
or
sign in
.
Regulatory actions for Aug. 18, 2021
Aug. 18, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Agios, Amo, Anaptysbio, Angel, Beigene, Biomind, Biontech, BMS, Corvus, Diamond, Emmaus, Eusa, GSK, Moderna, Nflection, Novartis, Pfizer, Roche, Virpax.
BioWorld
Briefs
Regulatory
Regulatory actions
Coronavirus